Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Liisa Pyhälä"'
Autor:
Anna-Maria Stucki, Päivi Hölttä, Jaana Mättö, J. Hannula, Maria Saarela, Satu Alaluusua, Sirkka Asikainen, H. Torkko, Hannele Jousimies-Somer, Liisa Pyhälä
Publikováno v:
Anaerobe. 2:19-27
To study intra-individual and intrafamilial clonal diversity of the putative periodontopathogens Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia/nigrescens group, family members of two children harbouring thes
Autor:
David T. O'Malley, Harri Saxen, Liisa Pyhälä, Anthony P. Moran, K Varkila, Jaana Vuopio-Varkila, Ilkka M. Helander
Lipopolysaccharides (LPS) of three strains of Campylobacter fetus (subspp. fetus and venerealis, and serotypes A and B), a bacterium of veterinary importance but also a cause of various infections in humans, were assessed for their ability to induce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6045d805ed55de9d888115697ffbd645
http://hdl.handle.net/10379/9579
http://hdl.handle.net/10379/9579
Publikováno v:
Journal of interferon research. 13(4)
Human interferon-gamma (IFN-gamma) has two N-linked glycosylation sites at positions 25 and 97 of the 143-amino-acid-long secretory form. To study the role of glycan residues in the pharmacokinetics of IFN-gamma, we produced recombinant IFN-gamma mol
Publikováno v:
Atherosclerosis. 52:123-126
The effect of bacterial lipopolysaccharide (LPS) on serum lipids was examined in rabbits. LPS was prepared from the smooth Salmonella typhimurium LT2 strain and given intravenously at a dose of 100 ng/kg b.wt. There were no significant changes in ser
Autor:
Liisa Pyhälä, Reijo Pyhälä
Publikováno v:
Journal of Virological Methods. 15:259-265
Hyperimmune rat antisera prepared against 5 recent antigenic variants of influenza A (H3N2) viruses were studied for haemagglutination inhibiting (HI) antibodies to the homologous and the heterologous viruses. The ratios of homologous to heterologous
Publikováno v:
Journal of Medical Microbiology. 25:197-203
A high degree of non-specific resistance to a lethal systemic Escherichia coli infection was induced in mice by pretreatment with a small dose (less than 5 micrograms/mouse) of the homologous lipopolysaccharide (LPS) or with heterologous rough-type L
Publikováno v:
Acta pathologica et microbiologica Scandinavica. Section B, Microbiology. 83(5)
Human leukocyte interferon proved to be a good immunogen in sheep, rabbits and guinea pigs. Sera from immunized animals neutralized the antiviral action of leukocyte interferon at high dilution. The highest anti-interferon titres obtained were 1:1,20
Autor:
Liisa Pyhälä, K. Cantell
Publikováno v:
The Journal of infectious diseases.
Most of the human leukocyte interferon or rabbit serum interferon administered intravenously to rabbits was detectabble in their plasma 1 min after injection. An increase in the dose did not affect the early clearance of human interferon but did prol
Publikováno v:
The Journal of general virology. 25(3)
Summary Intramuscular injection of concentrated human leucocyte interferon into mice, guinea pigs, rabbits, sheep and man gave a long-lasting plateau of circulating interferon. The relation between the interferon dose and the subsequent serum level w
Publikováno v:
Acta pathologica et microbiologica Scandinavica. Section C, Immunology. 86(2)
Daily subcutaneous injections of 5 to 10 million units of partially purified human leukocyte interferon were given to newborn rabbits for 2 weeks or 1 month. The control groups received mock interferon, saline or nothing. The interferon treatment had